S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Asian shares slip following technology selloff on Wall Street
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Tesla: How and Why It Gets To $300
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
AI-powered IoT Automation is Driving Samsara To New Highs
What is a Growth Stock Mutual Fund?
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Sprinklr Gets Targets Raised By Analysts, Here's Why
Time To Buy Uranium? Cameco Is The Top Pick
S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Asian shares slip following technology selloff on Wall Street
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Tesla: How and Why It Gets To $300
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
AI-powered IoT Automation is Driving Samsara To New Highs
What is a Growth Stock Mutual Fund?
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Sprinklr Gets Targets Raised By Analysts, Here's Why
Time To Buy Uranium? Cameco Is The Top Pick
S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Asian shares slip following technology selloff on Wall Street
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Tesla: How and Why It Gets To $300
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
AI-powered IoT Automation is Driving Samsara To New Highs
What is a Growth Stock Mutual Fund?
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Sprinklr Gets Targets Raised By Analysts, Here's Why
Time To Buy Uranium? Cameco Is The Top Pick
S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Asian shares slip following technology selloff on Wall Street
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Tesla: How and Why It Gets To $300
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
AI-powered IoT Automation is Driving Samsara To New Highs
What is a Growth Stock Mutual Fund?
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Sprinklr Gets Targets Raised By Analysts, Here's Why
Time To Buy Uranium? Cameco Is The Top Pick
NASDAQ:CPIX

Cumberland Pharmaceuticals (CPIX) Stock Forecast, Price & News

$1.62
0.00 (0.00%)
(As of 06/7/2023 ET)
Compare
Today's Range
$1.61
$1.78
50-Day Range
$1.59
$2.01
52-Week Range
$1.54
$2.91
Volume
33,413 shs
Average Volume
22,066 shs
Market Capitalization
$23.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CPIX stock logo

About Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock

Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the acquisition, development, and commercialization of prescription products. Its products include Acetadote, Caldolor, Kristalose, Omeclamox, Vaprisol, Vibativ, Sancuso, Boxaban, Vasculan. Dyscorban, and RediTrex. The company was founded by A. J. Kazimi on January 7, 1999 and is headquartered in Nashville, TN.

Receive CPIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

CPIX Stock News Headlines

The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Overnight fire in Cumberland County
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
CPIX: A Solid Stock with an Exciting Catalyst
See More Headlines

CPIX Price History

CPIX Company Calendar

Last Earnings
8/10/2021
Today
6/08/2023
Next Earnings (Estimated)
8/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceuticals
Sector
Medical
Current Symbol
NASDAQ:CPIX
CUSIP
23077010
Employees
83
Year Founded
1999

Profitability

Net Income
$-5,570,000.00
Pretax Margin
-10.00%

Debt

Sales & Book Value

Annual Sales
$42.01 million
Cash Flow
$0.47 per share
Book Value
$2.45 per share

Miscellaneous

Free Float
8,370,000
Market Cap
$23.41 million
Optionable
Optionable
Beta
0.34

Social Links


Key Executives

  • A. J. KazimiA. J. Kazimi
    Chairman & Chief Executive Officer
  • John M. Hamm
    Chief Financial & Accounting Officer
  • James L. Herman
    Chief Compliance Officer & Senior Vice President
  • Todd Anthony
    Executive Director-Organizational Development
  • Adam S. Mostafa
    Managing Director













CPIX Stock - Frequently Asked Questions

How have CPIX shares performed in 2023?

Cumberland Pharmaceuticals' stock was trading at $2.25 on January 1st, 2023. Since then, CPIX shares have decreased by 28.0% and is now trading at $1.62.
View the best growth stocks for 2023 here
.

When is Cumberland Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023.
View our CPIX earnings forecast
.

How were Cumberland Pharmaceuticals' earnings last quarter?

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced its quarterly earnings results on Tuesday, August, 10th. The specialty pharmaceutical company reported $0.08 earnings per share for the quarter, topping the consensus estimate of ($0.09) by $0.17. The specialty pharmaceutical company had revenue of $9.06 million for the quarter, compared to analyst estimates of $8.57 million. Cumberland Pharmaceuticals had a positive trailing twelve-month return on equity of 4.76% and a negative net margin of 9.97%.

What is A. J. Kazimi's approval rating as Cumberland Pharmaceuticals' CEO?

9 employees have rated Cumberland Pharmaceuticals Chief Executive Officer A. J. Kazimi on Glassdoor.com. A. J. Kazimi has an approval rating of 9% among the company's employees. This puts A. J. Kazimi in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Cumberland Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cumberland Pharmaceuticals investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), CymaBay Therapeutics (CBAY), Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), VBI Vaccines (VBIV), Akero Therapeutics (AKRO), Cerecor (CERC), Xeris Biopharma (XERS).

What is Cumberland Pharmaceuticals' stock symbol?

Cumberland Pharmaceuticals trades on the NASDAQ under the ticker symbol "CPIX."

Who are Cumberland Pharmaceuticals' major shareholders?

Cumberland Pharmaceuticals' stock is owned by a variety of retail and institutional investors. Top institutional investors include Dimensional Fund Advisors LP (4.23%), Renaissance Technologies LLC (3.97%) and BlackRock Inc. (0.92%). Insiders that own company stock include A J Kazimi, A J Kazimi, Caroline Young, James Jones, Joseph C Galante, Kenneth Krogulski, Martin E Cearnal, Martin E Cearnal and William Sumas.
View institutional ownership trends
.

How do I buy shares of Cumberland Pharmaceuticals?

Shares of CPIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cumberland Pharmaceuticals' stock price today?

One share of CPIX stock can currently be purchased for approximately $1.62.

How much money does Cumberland Pharmaceuticals make?

Cumberland Pharmaceuticals (NASDAQ:CPIX) has a market capitalization of $23.41 million and generates $42.01 million in revenue each year. The specialty pharmaceutical company earns $-5,570,000.00 in net income (profit) each year or ($0.28) on an earnings per share basis.

How can I contact Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals' mailing address is 2525 WEST END AVENUE SUITE 950, NASHVILLE TN, 37203. The official website for the company is www.cumberlandpharma.com. The specialty pharmaceutical company can be reached via phone at (615) 255-0068, via email at investors@cumberlandpharma.com, or via fax at 615-255-0094.

This page (NASDAQ:CPIX) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -